Healthcare GenAI market seen growing to $22b by 2027. Agentic artificial intelligence is accelerating documentation-heavy processes in biopharma, potentially shortening drug development timelines in ...

Oklo's stock surged on Trump's support for nuclear power, accelerating permitting timelines, but it remains highly volatile and speculative due to its pre-revenue status and uncertain profitability.

Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...